Related Experiment Video
Updated: Jan 14, 2026
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
3.4K
Insulin resistance and hypertension
Summary
Essential hypertension is linked to reduced insulin sensitivity, potentially due to angiotensin II (ANG II) interfering with insulin signaling pathways. This interference impacts vascular relaxation and glucose transport, contributing to diabetes risk.
Area of Science:
- Cardiovascular Physiology
- Metabolic Disorders
- Endocrinology
Background:
- Diminished insulin sensitivity is a hallmark of cardiometabolic syndrome, Type 2 diabetes, and hypertension.
- Individuals with essential hypertension exhibit a higher predisposition to developing diabetes compared to normotensive individuals.
- This propensity may stem from impaired insulin-mediated vascular relaxation and skeletal muscle glucose transport.
Discussion:
- Angiotensin II (ANG II), via its type 1 receptor, inhibits insulin's actions in vascular and skeletal muscle.
- ANG II interferes with insulin signaling through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathways.
- This inhibition is partly mediated by stimulated RhoA activity and increased oxidative stress.
Key Insights:
- Activated RhoA and reactive oxygen species impair PI3K/Akt signaling.
- This leads to reduced nitric oxide production by endothelial cells.
- Consequences include increased myosin light chain activation, vasoconstriction, and diminished skeletal muscle glucose uptake.
Outlook:
- Understanding the ANG II-insulin interaction is crucial for managing hypertension and diabetes.
- Targeting RhoA or oxidative stress may offer therapeutic strategies.
- Further research can elucidate mechanisms to restore insulin sensitivity in hypertensive patients.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
71.3K
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
9.1K
Related Concept Videos
01:29Hypertension II: Pathophysiology
771
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
771
01:18Hypertension and Regulation of Blood Pressure
3.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
581
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
581
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:17Antihypertensive Drugs: Action of β1 Blockers
1.9K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.9K